News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Vertex Pharmaceuticals
NEWS
JOBS
IN THE PRESS
NEWS
Pharm Country
Vertex May Be Turning Some Major Corners
August 14, 2017
·
1 min read
Pharm Country
For Vertex, Can One Billion-Dollar Breakthrough Beget Another?
August 9, 2017
·
1 min read
Drug Development
Vertex Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials
July 19, 2017
·
3 min read
Deals
3 Key Reasons Why a Gilead-Vertex Marriage May Not be a Match Made in Biotech Heaven
July 5, 2017
·
3 min read
Deals
Why Vertex Could Still Be Gilead’s Best Takeover Option
June 30, 2017
·
1 min read
Genetown
3 Biotechs That May Be Gearing Up For A Vertex-Like Run
June 9, 2017
·
1 min read
Policy
Tension Rises Between Vertex and Its Religious Investors Over Lobbying Disclosures
April 19, 2017
·
2 min read
Genetown
Vertex The Best Biotech Stock?
April 6, 2017
·
1 min read
Pharm Country
Is Vertex’s New CF Drug Unprecedented? Incremental? Expensive? Maybe All Three
March 30, 2017
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings - January 11, 2026
January 12, 2026
·
14 min read
Press Releases
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
December 23, 2025
·
1 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
December 8, 2025
·
15 min read
Press Releases
Vertex to Participate in the Citi’s 2025 Global Healthcare Conference on December 3
November 20, 2025
·
1 min read
Press Releases
Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week
November 10, 2025
·
11 min read
Press Releases
Vertex Reports Third Quarter 2025 Financial Results
November 3, 2025
·
20 min read
Press Releases
Vertex to Participate in the UBS Global Healthcare Conference on November 11
October 28, 2025
·
1 min read
Press Releases
Vertex Presents New Data Across Portfolio of Cystic Fibrosis Medicines Including ALYFTREK® at the North American Cystic Fibrosis Conference
October 24, 2025
·
15 min read
Press Releases
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week
October 20, 2025
·
10 min read
